Company Tauriga Sciences, Inc. Other OTC
Equities
TAUG
US87669X2053
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 12-08-21 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 17-07-04 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-14 |
Adina Miles
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 21-03-07 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 12-08-21 |
Director/Board Member | 46 | 21-03-07 | |
Director/Board Member | 75 | 15-08-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 299,908,214 | 299,908,214 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |